ATAAY yields 1.12% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, ATAAY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ATAAY + PFE for your $10,000?
Atacadão S.A. engages in the wholesale and retail of food, clothing, appliances, electronics, and other products in Brazil. The company operates through Retail, Atacadão, and Financial Solutions segments. The company offers alcoholic and non-alcoholic beverages; chocolate and cocoa powders, sugar and sweeteners, baby foods, rice, oats and cereals, cookies, toasts and snacks, coffee, teas, canned and uncanned products, sweets and deserts, flour, bean, yeast, grains and seed, pasta and sauces, mixture for bakery and confectionery, oils, fats and lard, soups and creams, and seasonings and condiments; and bathroom, kitchen, pool, clothing, and general cleaning products. It also provides personal hygiene and perfumery products; cold and diary products; meat, poultry, and fish products; packaging and disposables; frozen products; stationery and office products; and food baskets. The company offers its products through a chain of wholesale self-service and wholesale delivery stores, hypermarkets, supermarkets, convenience stores, gas stations, pharmacies, and e-commerce under the Carrefour and Atacadão brands. As of December 2020, it operated 721 stores. In addition, the company also credit cards and consumer finance, and other products, such as insurance policies. Atacadão S.A. is based in São Paulo, Brazil.
Full ATAAY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.